A recent education partnership between Curaleaf Laboratories and The Medical Cannabis Clinicians Society reflects a long-term commitment to advancing standards, building confidence across the healthcare community, and ensuring the sector can grow responsibly.
Strengthening clinician education is essential if the UK is to realise the full potential of its medical cannabis framework, Jonathan Hodgson, UK Managing Director at Curaleaf International, explained:
“We’ve helped patients and clinicians alike address unmet clinical needs through unlicensed medicines for a long time. While the adoption of medical cannabis is only in its infancy, we want to help widen access to this option.”
While the UK is currently the second largest medical cannabis market in Europe, access for patients remains limited.
One of the biggest barriers is education for clinicians. Education is a core principle in Curaleaf’s strategy. We are excited by this partnership that establishes a strong foundation to build a platform and empower prescribers to improve patient care.
Read more on the Business of Cannabis website.
